BETd-246

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

BETd-246  纯度: 98.04%

BETd-246 是第二代、基于 PROTAC 技术的、 BET溴端结构域 (BRD) 的抑制剂，由Cereblon配体和BET配体相连，具有良好的选择性、有效性和抗肿瘤活性。

BETd-246

BETd-246 Chemical Structure

CAS No. : 2140289-17-2

规格 价格 是否有货 数量
5 mg ￥6500 In-stock
10 mg ￥9500 In-stock
25 mg ￥19500 In-stock
50 mg ￥29500 In-stock
100 mg   询价  
200 mg   询价  

* Please select Quantity before adding items.

BETd-246 相关产品

•相关化合物库:

  • Bioactive Compound Library Plus

生物活性

BETd-246 is a second-generation and PROTAC-based BET bromodomain (BRD) inhibitor connected by ligands for Cereblon and BET, exhibiting superior selectivity, potency and antitumor activity[1].

IC50 & Target

BET BRD[1].
体外研究
(In Vitro)

BETd-246 treatment (0-100 nM, 1-3 h) causes a dose-dependent depletion of BRD2, BRD3 and BRD4 in representative TNBC cell lines with 30-100 nM for 1 h or with 10-30 nM for 3 h incubation.
BETd-246 (100 nM, 24/48 hours) displays strong growth inhibition and apoptosis induction activity in MDA-MB-468 cell lines. BETd-246 induces a rapid and time-dependent downregulation of MCL1 protein in all the TNBC cell lines evaluated. BETd-246 induces much stronger apoptosis than BETi-211.
BETd-246 (100 nM, 24 hours) induces pronounced cell cycle arrest and apoptosis in TNBC cell lines[1].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay[1]

Cell Line: MDA-MB-468 cells
Concentration: 100 nM
Incubation Time: 24 or 48 hours
Result: Displayed strong growth inhibition and apoptosis induction activity in TNBC cell lines.

Cell Cycle Analysis[1]

Cell Line: Human TNBC cells
Concentration: 100 nM
Incubation Time: 24 hours
Result: Induced pronounced cell cycle arrest and apoptosis in TNBC cell lines.

Western Blot Analysis[1]

Cell Line: Human TNBC cells
Concentration: 0-100 nM
Incubation Time: 1-3 hours
Result: Caused a dose-dependent depletion of BRD2, BRD3 and BRD4.

体内研究
(In Vivo)

BETd-246 (5 mg/kg, IV, 3 times per week for 3 weeks) treatment effectively inhibits WHIM24 tumor growth, similar to the antitumor activity of BETi-211 with higher dosage and more frequently administration. The treatment of 10 mg/kg induces partial tumor regression during treatment without apparent toxicity. BETd-246 has very limited drug exposure in the xenograft tumor tissue in MDA-M-231and MDA-MB-468 models[1].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: “Washington Human in Mouse (WHIM)” (PDX) model developed from a patient with treatment-resistant breast cancer (ESRE380Q, PR- and HER2-))[1].
Dosage: 5, 10 mg/kg
Administration: IV, 3 times per week for 3 weeks.
Result: Effectively inhibited WHIM24 tumor growth.

分子量

946.02

Formula

C48H55N11O10
CAS 号

2140289-17-2
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

-20°C, stored under nitrogen

*In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)
溶解性数据
In Vitro: 

DMSO : 200 mg/mL (211.41 mM; Need ultrasonic)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 1.0571 mL 5.2853 mL 10.5706 mL
5 mM 0.2114 mL 1.0571 mL 2.1141 mL
10 mM 0.1057 mL 0.5285 mL 1.0571 mL

*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80°C, 6 months; -20°C, 1 month (stored under nitrogen)。-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液，再依次添加助溶剂：

——为保证实验结果的可靠性，澄清的储备液可以根据储存条件，适当保存；体内实验的工作液，建议您现用现配，当天使用； 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比；如在配制过程中出现沉淀、析出现象，可以通过加热和/或超声的方式助溶

  • 1.

    请依序添加每种溶剂： 10% DMSO    90% corn oil

    Solubility: ≥ 5 mg/mL (5.29 mM); Clear solution

    此方案可获得 ≥ 5 mg/mL (5.29 mM，饱和度未知) 的澄清溶液，此方案不适用于实验周期在半个月以上的实验。

    以 1 mL 工作液为例，取 100 μL 50.0 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中，混合均匀。

*以上所有助溶剂都可在 上海金畔生物科技有限公司 网站选购。
参考文献

  • [1]. Bai L, et al. Targeted Degradation of BET Proteins in Triple-Negative Breast Cancer. Cancer Res. 2017 May 1;77(9):2476-2487.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务